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Transgenic mice have been produced that either lack or
overproduce neuroregulatory substances implicated in
the control of food intake and body weight. Are such
mice useful models for understanding the underlying
etiology of obesity in humans?
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In recent years, the genes underlying most of the major
inherited obesity disorders in the mouse have been cloned,
and several transgenic mouse strains have been produced
that misexpress regulators of body weight. We classify the
genetic manipulations into three groups: those targeting a
protein produced in a restricted number of sites outside the
central nervous system (CNS); those targeting a broadly
expressed regulator of energy metabolism; and those tar-
geting brain neuroregulators and neurotransmitters. We
shall try to assess what has been learned from these studies.
Regulators with restricted expression outside the CNS
The crucial role of body-to-brain signaling in weight
regulation is evident from the obese (ob/ob) mouse. The
gene affected by the ob mutation was cloned four years
ago, and found to encode a signaling molecule dubbed
leptin [1]. Without effective leptin, ob/ob mice are very
obese, infertile and lethargic. Leptin injections, most
effectively in the CNS, reverse these abnormalities.
Leptin receptors have since been found in key brain sites.
It is generally agreed that leptin is a signal necessary for
normal body-weight regulation.
At the same time, others have demonstrated the impor-
tance of certain peripheral effectors with respect to energy
metabolism. Lowell et al. [2] found that, in mice express-
ing a cell-lethal gene from a brown-fat-specific promoter,
the lack of brown fat caused serious obesity that included
hyperphagia. But knocking out the gene encoding ‘uncou-
pling protein’, thought to be the key thermogenic protein
in brown adipose tissue, did not produce obesity. These
observations were helpful in prompting the successful
search for other uncoupling proteins, now known to be
expressed in brown fat as well as other tissues.
The enhancer/promoter region of the aP2 gene, which
encodes the adipocyte lipid-binding protein, has been used
to direct expression of a specific cDNA to adipose tissue,
which has allowed greater knowledge of fat cell function.
Such a method has, for example, been used to produce mice
that overexpress the beta 1-adrenergic receptor in adipose
tissue [3]. These transgenic mice are somewhat resistant to
diet-induced obesity, and have smaller adipose tissue
deposits. Others have produced mice that overexpress
glucose transporter-4 in white and brown fat [4]; they
showed a 2–3-fold increase in total body lipid, an increase in
fat cell number and obesity. Overexpression of uncoupling
protein in white and brown fat prevented the development
of obesity in the yellow (Ay) mutant mouse (see below) [5].
Widely expressed regulators of energy metabolism
Genetic manipulation can identify previously unknown
regulators of energy balance. For example, knockout mice
deficient in intercellular adhesion molecule-1 (ICAM-1)
became obese in old age, despite a normal feeding regime
[6]. When fed a high-fat diet, these mice became obese at a
young age. Knockout mice deficient in the counter-recep-
tor for ICAM-1, the leukocyte integrin αMβ2 (Mac-1), also
became obese, despite eating similar quantities of food to
wild-type mice, suggesting that leukocyte function might
influence energy expenditure. 
Another example involves basic-helix–loop–helix pro-
teins [7], which include transcription factors involved in
growth and development. Loss of such a transcription
factor, Nhlh2, made in the ventro-medial and lateral
hypothalamus, has sex-specific effects: male mutants are
hypogonadal and infertile, and lack instinctive male
sexual behavior; female mutants are also hypogonadal,
but when housed with males develop normal ovaries and
uteri. Both male and female mutants display adult-onset
obesity, implicating Nhlh2 in some aspect of the regula-
tion of energy metabolism. A last example concerns cyclic
AMP, long known to have effects on cellular metabolism
mediated by protein kinase A (PKA), which has two regu-
latory and two catalytic subunits. Knocking out the gene
for the RII regulatory subunit of PKA creates a mouse
with very little white adipose tissue, even though food
intake is normal [8].
Brain neuromodulators
The experience with genetic manipulation of brain regu-
lators has been illuminating in some cases, but in others
the results have been difficult to interpret. One mutation
that gives a relatively clear picture is the diabetic (db/db)
mouse, which is diabetic and infertile as well as obese, all
of which are caused by a splicing defect resulting in an
ineffective leptin receptor [9]. This observation under-
lines the importance of an effective leptin signal from
adipose tissue to the brain, as the most important site of
leptin receptors action appears to be in the hypothalamus. 
Results that appear to permit straightforward interpretation
have also been obtained for the melanocortin receptor
system. The yellow mouse overexpresses the Agouti protein,
which competes with melanocyte-stimulating hormone for
binding to melanocortin-4 receptors, resulting in obesity.
Knocking-out the melanocortin-4 receptor gene produced
mice that developed a maturity-onset obesity syndrome
resembling that associated with Agouti overproduction,
including hyperphagia, hyperinsulinemia and hyper-
glycemia [10]. Somewhat similar observations have recently
been reported for one type of bombesin receptor. Bombesin
is a peptide isolated from frog skin that was found to
decrease food intake in several species. Mammalian genes
for bombesin-like peptides, which bind to G-protein-
coupled receptors, have been cloned. Ohki-Hamazaki et al.
[11] have found that knockout mice lacking the bombesin
receptor subtype-3 become mildly obese, are hypertensive
and have impaired glucose metabolism. 
In each of the three cases described above, the results can
be interpreted as indicating that the particular receptor has
a significant role in the regulation of energy metabolism.
Interpretation is less straightforward in the case of neuro-
peptide Y (NPY). Injection of NPY into the hypothalamic
paraventricular nucleus dramatically increases food intake,
decreases thermogenesis and increases white fat lipoprotein
lipase activity and gene expression [12]; chronic injection of
NPY produces significant obesity. NPY gene expression
increases in conditions associated with an energy deficit,
such as food deprivation, high activity, diabetes or lactation.
But NPY knockout mice show normal food intake and body
weight, and respond appropriately to food deprivation and
leptin administration [13]. There is no agreed explanation
that reconciles these observations, though one likely factor
is that energy metabolism is regulated by redundant mech-
anisms that can substitute for NPY when it is absent during
development. Support for this position comes from the
phenotype of ob/ob mutants that also lack NPY, which show
half the obesity of the ob/ob strain [14].
Another complex example is the dopamine-deficient
mouse, generated by knocking out the tyrosine hydroxylase
gene [15]. Dopamine-deficient mice become hypoactive
and stop eating within a few weeks after birth. Within
minutes of being injected with L-dihydroxyphenylalanine
(L-DOPA), they become active and eat more food than
control mice. In this case, specificity is an important issue,
as dopamine is known to serve many functions besides the
regulation of food intake, and general activity and motor
functions may be significantly impaired in the mutant mice.
Studies of the CNS indicate that body-weight regulation
occurs through a complex network involving many brain
nuclei. Modifying the synthesis of neuroregulators at all
sites and developmental times is a relatively crude way of
investigating their function, which can give an over-simple
picture of the relevant regulatory pathways. While knock-
out mice models are useful, the lack of any obvious effect
on food intake or body weight of a targeted mutation does
not mean that the affected gene product can be ruled out
as being involved in the regulation of energy metabolism.
If one regulator is missing, others can become more salient,
and new regulators are constantly being identified. For
example, two novel hypothalamic neuropeptides that stim-
ulate feeding, orexin-A and orexin-B, have recently been
discovered [16]. Production of these peptides is enhanced
in food-deprived rats, as has been noted for other neu-
ropeptides involved in energy metabolism, such as NPY.
The effects of modulating gene expression at specific sites
and time should lead to a better understanding of the part
the gene product plays in body-weight management, and
undoubtedly such technologies will be available soon.
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